Emergency Zika Vaccine Could be Ready by October

A vaccine for the Zika virus, being developed by a consortium, including Inovio Pharmaceuticals, Inc. INO, could be ready for emergency use by October, according to a report by Reuters on Thursday. The vaccine is being developed by U.S. and Canadian scientists and could be ready for human trials by September, subject to regulatory approval. A collaboration on development of a Zika virus vaccine between Inovio and Korea's GeneOne Life Science was announced on January 22. Inovio closed Thursday at $5.78, up $0.41.